Oral bisphosphonate use and all-cause mortality in patients with moderate-severe (grade 3B-5D) chronic kidney disease: a population-based cohort study

Osteoporosis

Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a bi-national cohort analysis

J Bone Miner Res

Robinson DE, Ali MS, Pallares N, Tebé C, Elhussein L, Abrahamsen B, Arden NK, Ben-Shlomo Y, Caskey FJ, Cooper C, Dedman D, Delmestri A, Judge A, Pérez-Sáez MJ, Pascual J, Nogues X, Diez-Perez A, Strauss VY, Javaid MK, Prieto-Alhambra D

doi: 10.1002/jbmr.4235

Rheumatoid Arthritis

Survival benefit of statin use in ankylosing spondylitis: a general population-based cohort study

Ann Rheum Dis

Oza A, Lu N, Schoenfeld SR, Fisher MC, Dubreuil M, Rai SK, Zhang Y, Choi HK

doi: 10.1136/

Further Publications Dermatology

Use of oral antidepressants in patients with chronic pruritus: A systematic review

J Am Acad Dermatol.

Kouwenhoven TA, van de Kerkhof PCM, Kamsteeg M

doi: 10.1016/j.jaad.2017.08.025.

Psoriatic Arthritis

Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study

Rheumatology (Oxford).

Charlton R, Green A, Shaddick G, Snowball J, Nightingale A, Tillett W, Smith C, McHugh N; PROMPT study group

doi: 10.1093/rheumatology/key286.

AcneAlopecia AreataPsoriasisVitiligo

Risk of Skin Disorders in Patients with Celiac Disease: A Population-Based Cohort Study

J Am Acad Dermatol

Lebwohl B, Söderling J, Roelstraete B, Lebwohl MG, Green PH, Ludvigsson JF

doi: 10.1016/j.jaad.2020.10.079

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

Ann Rheum Dis.

Pablos JL, Galindo M, Carmona L, Lledó A, Retuerto M, Blanco R, Gonzalez-Gay MA, Martinez-Lopez D, Castrejón I, Alvaro-Gracia JM, Fernández Fernández D, Mera-Varela A, Manrique-Arija S, Mena Vázquez N, Fernandez-Nebro A, RIER Investigators Group., RIER investigators group

doi: 10.1136/annrheumdis-2020-218296.

Rheumatoid Arthritis

Trends in all-cause and cardiovascular mortality in patients with incident rheumatoid arthritis: a 20-year follow-up matched case-cohort study

Rheumatology (Oxford).

Provan SA, Lillegraven S, Sexton J, Angel K, Austad C, Haavardsholm EA, Kvien TK, Uhlig T

doi: 10.1093/rheumatology/kez371.

Systemic Lupus Erythematosus

Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus

Rheumatology (Oxford).

Li D, Yoshida K, Feldman CH, Speyer C, Barbhaiya M, Guan H, Solomon DH, Everett BM, Costenbader KH

doi: 10.1093/rheumatology/kez288.

Further Publications Immunology

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

Lancet.

Feagan BG, Sandborn WJ, D'Haens G, Panés J, Kaser A, Ferrante M, Louis E, Franchimont D, Dewit O, Seidler U, Kim KJ, Neurath MF, Schreiber S, Scholl P, Pamulapati C, Lalovic B, Visvanathan S, Padula SJ, Herichova I, Soaita A, Hall DB, Böcher WO

doi: 10.1016/S0140-6736(17)

Related content

Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a bi-national cohort analysis

Survival benefit of statin use in ankylosing spondylitis: a general population-based cohort study

Use of oral antidepressants in patients with chronic pruritus: A systematic review

Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study

Risk of Skin Disorders in Patients with Celiac Disease: A Population-Based Cohort Study

Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

Trends in all-cause and cardiovascular mortality in patients with incident rheumatoid arthritis: a 20-year follow-up matched case-cohort study

Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study